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This study aims to perform gene diagnosis
for Chinese family patients with Oculophar-
yngeal muscular dystrophy (OPMD). Geno-
mic DNAs were extracted from the
pedigrees’ members. Gene diagnosis was
performed for these pedigrees’ members by
approaches, such as DNA sequencing and
GeneScan. Sequence analysis and
PABPN1 genotyping showed that the mu-
tated allele in affected members of this family
has nine trinucleotide repeats of GCG
(GCG)9, whereas the normal allele contains
six trinucleotide repeats of GCG (GCG)6.
The above results suggest that mutated
GCG repeats in PABPN1 gene may cause
OPMD in this family, and PABPN1 genotyp-
ing could be used as a convenient, highly
effective, and reliable gene diagnostic test
for OPMD patients. J. Clin. Lab. Anal.
24:422–425, 2010. r 2010 Wiley-Liss, Inc.
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INTRODUCTION
Oculopharyngeal muscular dystrophy (OPMD) is a
late-onset autosomal dominant genetic disorder char-
acterized by eyelid drooping (ptosis) and swallowing
difficulty (dysphagia) (1). OPMD was largely reported
in Caucasian families, especially of French-Canadian
trait. Several cases in Asians were reported. The onset of
OPMD is usually during the fifth or sixth decade of life,
and all patients are symptomatic beyond the age of 70.
A spectrum of mutations (GCG)8–13 (GCA)3 (GCG)
was found in cohorts studied throughout the world
(2–4). Here, we report an OPMD case in a Chinese
family with four members affected, describe their clinical




We found an OPMD family from Fujian Province in
China (Fig. 1). All seven members of the OPMD family
received electrophysiological examinations (Table 1).
The proband is a 78-year-old woman, who suffers from
ptosis and dysphagia with solids and liquids. In
neurological examinations, there are limitations for the
ocular movement in all directions, especially for the
extra-ocular movement. She is also noted to be having
difficulty in climbing down the stairs. In this family with
ten members, four members are affected (one male and
three females). Three members are asymptomatic young
persons (all females) but with a mutated PABPN1 gene.
The other three are normal. The II:1 is a 58 year old
man, who has weakness in the legs to the extent that he
has difficulty in going up and down the stairs. He has a
history of bilateral ptosis for 5 years and has been
coughing while drinking for the past 4 years. Neurolo-
gical examinations showed that his ocular movement is
normal but his deep tendon reflex is reduced in four
limbs. The strength of his bilateral sternocleidomastoid
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muscles is MRC grade 4 (diminished power). He also
shows a duplication of right thumbs. The II:2 is a 56
year old woman who has been suffering from bilateral
ptosis and has difficulty swallowing for the past 3 years.
Clinical examination shows that her deep tendon reflex
is reduced in the upper and lower limbs. The strength in
her bilateral sternocleidomastoid muscles is MRC grade 4.
The II:3 is a 53 year old woman, who has difficulty
swallowing for the past 4 years. Both the II:4 and the
II:5 are male, aged 48 and 42, respectively. Neither of
them shows any neurological symptoms. The III:1-3 are
asymptomatic of young persons and the III:4 in normal
ones. Their ages, in the third generation, are all under
30 years old. With the family members’ informed
consent, their blood samples were collected for screening
PABPN1 gene with possible expansions in the GCG
repeat sequence, and genomic DNAs were extracted
from the pedigrees’ members.
Methods of the DNA Sequencing Analysis
The repeat sequence of genomic DNAs was amplified by
PCR using PABP-F Primer (50-CGCAGTGCC-
CCGCCTTAGA-30) and PABP-R Primer (50-ACAA-
GATGGCGCCGCCGCCCCGGC-30) as described by
Braid et al. (5). The amplification was carried out on a
Mastercycler gradient (Eppendorf, Hamburg, Germany)
with an initial denaturation reaction at 941C for 20min,
followed by a 35-cycle reaction of 941C for 1min, 641C for
1min, and 721C for 1min, and the final elongation reaction
was at 721C for 7min. The PCR product was purified
by 2.0% agarose gel electrophoresis stained with SYBR
Green I. The 230bp fragment was isolated using the
QIAEX kit (Qiagen, Hilden, Germany) and subsequently
cloned into the vector pUC19 using a pUC19-T cloning kit
(TaKaRa, Shiga, Japan). The recombinant plasmid was
finally transformed into E. coli DH5a using standard
procedures (6). The amplified recombinant plasmid DNA
was isolated by the alkaline lysis method (7). Both purified
PCR products and the recombinant plasmids were
sequenced by an Applied Biosystems 3130 Genetic
Analyzer (Applied Biosystems, Foster City, CA).
TABLE 1. Clinical Data of a Chinese Family With Oculopharyngeal Muscular Dystrophy
Probands I-1 II-1 II-2 II-3 III-1 III-2 III-3
Age (years) 78 58 56 53 o30 o30 o30
Sex F M F F F F F
Age of onset (years) 65 53 53 49   
Clinical manifestations
Initial symptom Dysphagia or ptosis Dysphagia or ptosis Dysphagia or ptosis Dysphagia   
Ptosis 11 11 11    
Dysphagia to solid food 11 11 11 1   
Time to swallow 250ml of cold water 30.46 25.14 20.76 17.83 NA NA NA
Dysphonia 1      
Proximal limb weakness       
Sternocleidomastoid muscle weakness  1 1    
Nasal regurgitation 1 1     
Limitation of EOM 2 0 0 0 0 0 0
Gait disturbance       
CK, ref: 20–180 IU/l 122 83 130 56 44 51 79
EKG Normal Normal Normal Normal Normal Normal Normal
NCV/EMG Myopathic Myopathic Normal Normal Normal Normal Normal
Other diseases DM DM DM    
OM, eye movement. From 0 to 4 represents none to full limitation; CK, serum creatine kinase; EKG, electrocardiogram; NCV/EMG, nerve
conduction study/electromyogram; F, female; M, male; swallowing time (sd: 2 sec); , absent; 1, mild impairment; 11, moderate impairment;
NA, not available; DM, diabetes mellitus.
 I:1   
III:1 
II:1 II:2 II:3 II:4 II:5 
III:2 III:3 III:4 
Fig. 1. The genealogical tree of a Chinese OPMD family shows a
dominantly inherited disorder affecting seven family members in three
generations. All affected individuals (black symbol) are heterozygous
for the mutation (GCG)9. Individuals of III:1, 2, 3 are asymptomatic
young persons (gray symbol), who are also heterozygous for the
mutation (GCG)9. The arrow indicates the proband. The symbol circle
and square stand for female and male, respectively.
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Methods of the GeneScan Analysis
A GeneScan analysis was applied in the OPMD
diagnosis. DNA samples from OPMD patients and
normal persons were analyzed by PCR amplification,
essentially as described above, but the reverse primer
was labeled with fluorescent HEX (hexachlorofluores-
cein) at its 50 end. The PCR products were separated
according to their sizes by capillary electrophoresis on
an Applied Biosystems 3130 Genetic Analyzer (Applied
Biosystems). Loading cocktails included a 9.5ml
Hi-DiTM Formamide (Applied Biosystems) and a
0.5ml ILS600 ladder (Promega, Madison, WI). The
electrokinetic injection was carried out at 3 kV for 5 sec
and the running voltage is 15 kV. The standard running
conditions include a 36 cm capillary array, a 3,130
POP-4TM polymer and 1Genetic Analyzer Buffer
with EDTA (all from Applied Biosystems). Running
files were analyzed by the GeneMapper 3.2 software
with a 50 RFU analysis threshold.
RESULTS
DNA Sequencing Analysis
The purified PCR products and recombinant plasmids
were sequenced by an Applied Biosystems 3130 Genetic
Analyzer. In DNA samples of I:1, II:1-3, and III:1-3,
sequencing analysis showed that all of them have one
allele of PABPN1 gene with nine repeats of GCG-
trinucleotide and the other allele with only six repeats.
But II:4, II:5, and III:4 have six repeats of GCG-
trinucleotide in both alleles of PABPN1 gene (Fig. 2).
GeneScan Analysis
Results obtained by the GeneScan analysis were in
accord with DNA sequencing analysis (Fig. 3). The
allele of PABPN1 gene at this locus has two copies of
(GCG)6 with a 18 bp sequence. But the allele of the
mutated PABPN1 gene at this locus has one copy of
the (GCG)6 with a 18 bp sequence and one copy of the
(GCG)9 with a 27 bp sequence. The difference between
the allele (GCG)6 and (GCG)9 is 9 bp sequence.
DISCUSSION
We described an OPMD family found in Fujian
Province, China. The diagnosis by genotyping applied in
this family shows a heterozygous abnormal expansion of
GCG trinucleotide repeats in PABPN1 gene, which is
one of the most commonly recognized gene related to
OPMD (5,8). OPMD is rarely reported in Asians,
especially in Chinese populations. Goh et al. reported a
Fig. 2. Sequencing of PABPN1 genes from both unaffected persons and from OPMD patients. In Panel A, the arrow indicates the normal
allele with 6-GCG repeats in PABPN1 gene. In Panel B, the arrow shows the expanded allele with 9-GCG repeats in PABPN1 gene.
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Malaysian family of Chinese descent with autosomal
dominant OPMD (9). Kuo et al. found an insertion of
(GCG)4 GCA in the PABPN1 gene in the Taiwanese
OPMD subjects (10). Although a few OPMD patients
in mainland China have been reported, few cases
have been genetically confirmed. Liu et al. reported the
first OPMD family confirmed genetically in mainland
China (11). They found the abnormal expansions of
(GCG)8 and (GCG)10 repeats in the PABPN1 gene
using DNA sequencing in three OPMD families (11).
Here, we report another OPMD family in mainland
China. The abnormal expansion of (GCG)9 repeats is
found in one allele of their PABPN1 gene.
The paucity of reported cases suggests that OPMD is
an uncommon disorder in Chinese populations. How-
ever, the condition could be underrecognized as the
symptoms of this disorder appear in later life and may
even not be noticed in the initial stages, just as those
found in III: 1, 2, 3 of this family. Therefore, medical
attentions could be never paid to these cases since they
lack of symptoms. This report highlights the existence of
this form of muscular dystrophy in China.
It is estimated that 99% of patients diagnosed with
severe, autosomal dominant OPMD actually carry a
pathogenic PABPN1-triplet repeat expansion (12).
Therefore, expansion analysis of GCG-triplet repeats
in PABPN1 gene is a reliable gene diagnostic test for
OPMD. It only takes about 5 hr to determine the
normal and the expanded alleles of GCG repeats by a
complete GeneScan analysis, which is faster and more
convenient than using DNA sequencing assay.
In summary, we report a Chinese OPMD family
confirmed genetically. Our results suggest that PABPN1
genotyping could be used as a convenient, highly effective,
and reliable gene diagnostic test for OPMD patients.
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12. Rüegg S, Hagen ML, Hohl U, et al. Oculopharyngeal muscular
dystrophy an underdiagnosed disorder? Swiss Med Wkly
2005;135:574–586.
Fig. 3. PABPN1 genotyping by a GeneScan analysis. The number
beneath each peak is the estimated size (bp) of DNA fragments.
Panel A shows that an unaffected individual has 6-GCG repeats in both
alleles in his PABPN1 gene. Panel B shows that the PABPN1 gene from
an affected individual has one allele with 6-GCG repeats and one allele
with an expanded 9-GCG repeats.
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